Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Positive Q4 rounds off steady 2008 for LabCorp

This article was originally published in Clinica

Executive Summary

Both revenues and net income grew for LabCorp during the fourth quarter, rounding off a solid fiscal 2008 for the Burlington, North Carolina firm. Sales for the quarter increased 11% to $1.12bn on the back of increased testing volume. The revenue growth benefited the firm’s earnings, which were $118.1m, up from $114.4m the previous year. For the full year, sales also climbed 11% to $4.51bn, compared with $4.07bn recorded in 2007. However, net income was down from $476.8m in 2007 to $464.5m, due to higher cost of sales and general expenses.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042629

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel